Pro-Dex, Inc. (PDEX)
|Net Income (ttm)||6.14M|
|Trading Day||May 13|
|Day's Range||32.50 - 33.89|
|52-Week Range||16.76 - 42.60|
IRVINE, CA / ACCESSWIRE / May 6, 2021 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2021 third quarter ended March 31, 2021.
Phoenix, Arizona--(Newsfile Corp. - February 11, 2021) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufactu...
Phoenix, Arizona--(Newsfile Corp. - November 11, 2020) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufactu...
Growth-focused investors may be interested in the following stocks since their price-earnings ratios still trade below 20 and their trailing 12-month earnings per share have grown significantly over the...
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, Calif... [Read more...]
Medical Instruments & Supplies
Richard Van Kirk
|Stock Exchange |
|Ticker Symbol |
In 2020, Pro-Dex's revenue was $34.83 million, an increase of 28.20% compared to the previous year's $27.17 million. Earnings were $6.11 million, an increase of 47.35%.
According to one analyst, the rating for Pro-Dex stock is "Strong Buy" and the 12-month stock price forecast is 41.00.